Literature DB >> 22183481

Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia.

Rodrigo Del Rio1, Esteban A Moya, María J Parga, Carlos Madrid, Rodrigo Iturriaga.   

Abstract

Chronic intermittent hypoxia (CIH), a main feature of obstructive sleep apnoea (OSA), increases hypoxic ventilatory responses and elicits hypertension, partially attributed to an enhance carotid body (CB) responsiveness to hypoxia. As inflammation has been involved in CIH-induced hypertension and chemosensory potentiation, we tested whether ibuprofen may block CB chemosensory and cardiorespiratory alterations induced by CIH in a rat model of OSA. We studied the effects of ibuprofen (40 mg · kg(-1) · day(-1)) on immunohistochemical interleukin (IL)-1β and tumour necrosis factor (TNF)-α levels in the CB, the number of c-fos-positive neurons in the nucleus tractus solitarii (NTS), CB chemosensory and ventilatory responses to hypoxia, and arterial blood pressure in male rats either exposed for 21 days to 5% O(2) (12 episodes · h(-1), 8 h · day(-1)) or kept under sham condition. CIH increased CB TNF-α and IL-1β and c-fos-positive neurons in the NTS, enhanced carotid chemosensory and ventilatory hypoxic responses, and produced hypertension. Ibuprofen prevented CB cytokine overexpression and CIH-induced increases in c-fos-positive neurons in the NTS, the enhanced hypoxic ventilatory responses and hypertension, but failed to impede the CB chemosensory potentiation. Results suggest that pro-inflammatory cytokines may contribute to the CIH-induced cardiorespiratory alterations, acting at several levels of the hypoxic chemoreflex and cardiovascular control pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183481     DOI: 10.1183/09031936.00141511

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  51 in total

Review 1.  Respiratory rhythm generation, hypoxia, and oxidative stress-Implications for development.

Authors:  Alfredo J Garcia; Jean Charles Viemari; Maggie A Khuu
Journal:  Respir Physiol Neurobiol       Date:  2019-07-29       Impact factor: 1.931

2.  Commentary on CPAP vs. oxygen for treatment of OSA.

Authors:  Shirin Shafazand; M Safwan Badr
Journal:  J Clin Sleep Med       Date:  2014-11-15       Impact factor: 4.062

Review 3.  Apneic Sleep, Insufficient Sleep, and Hypertension.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 4.  Sleep, death, and the heart.

Authors:  Meghna P Mansukhani; Shihan Wang; Virend K Somers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-17       Impact factor: 4.733

Review 5.  The impact of inflammation on respiratory plasticity.

Authors:  Austin D Hocker; Jennifer A Stokes; Frank L Powell; Adrianne G Huxtable
Journal:  Exp Neurol       Date:  2016-07-27       Impact factor: 5.330

Review 6.  Sex differences in sleep apnea and comorbid neurodegenerative diseases.

Authors:  Brina Snyder; Rebecca L Cunningham
Journal:  Steroids       Date:  2017-12-16       Impact factor: 2.668

Review 7.  Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease.

Authors:  Omar A Mesarwi; Rohit Loomba; Atul Malhotra
Journal:  Am J Respir Crit Care Med       Date:  2019-04-01       Impact factor: 21.405

Review 8.  Role of neurotransmitter gases in the control of the carotid body in heart failure.

Authors:  Harold D Schultz; Rodrigo Del Rio; Yanfeng Ding; Noah J Marcus
Journal:  Respir Physiol Neurobiol       Date:  2012-07-25       Impact factor: 1.931

9.  Sustained exposure to cytokines and hypoxia enhances excitability of oxygen-sensitive type I cells in rat carotid body: correlation with the expression of HIF-1α protein and adrenomedullin.

Authors:  Xuemei Liu; Liang He; Bruce Dinger; Larry Stensaas; Salvatore Fidone
Journal:  High Alt Med Biol       Date:  2013-03       Impact factor: 1.981

Review 10.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.